Skip to main content
. 2010 Jul 23;182(12):1498–1505. doi: 10.1164/rccm.201002-0151OC

TABLE 1.

BASELINE DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF THE ECLIPSE AND ICGN POPULATIONS

ECLIPSE ICGN
COPD Cases Probands Siblings
Subjects, n 1,609 606 1,285
Age, ± SD 63.8 (± 7.1) 58.4 (± 5.4) 58 (± 9.8)
Female, % 32.5 40.3 49.8
Post-bronchodilator FEV1, % predicted, ± SD 48.1 (± 15.6) 36.2 (± 12.9) 77.5 (± 25.9)
Post-bronchodilator FEV1/FVC ratio*, ± SD 0.45 (± 0.11) 0.37 (± 0.12) 0.61 (± 0.15)
Pack-years of smoking, ± SD 50.9 (± 28) 51.5 (± 26.7) 40.5 (± 24.6)
Current smoker, % 35.5 33.83 50.82
Body mass index, ± SD 26.7 (± 5.6) 26.1 (± 6.2) 27.2 (± 6.5)
Fat-free body mass, ± SD 50 (± 10.2)
BODE index, ± SD§ 3.2 (± 2.1)
Frequency of exacerbation in the past 12 mo, ± SD 0.83 (± 1.20)
Frequency of exacerbation (2-yr follow-up), ± SD 2.12 (± 2.62)
Quantitative emphysema, −950 HU, ± SD 18 (± 12) 22.3 (± 14.4) 16.08 (± 10.9)
Radiologist score, % subjects with >5% emphysema 66.7 80.8 39.3
Airway wall thickness, mm, Pi10, ± SD 3.96 (± 0.21) 4.86 (± 0.43) 4.78 (± 0.44)

Definition of abbreviations: BODE = body mass index, airflow obstruction, and exercise capacity; COPD = chronic obstructive pulmonary disease; ECLIPSE = Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-point; ICGN = International COPD Genetics Network.

A total of 110 subjects from ICGN who also participated in the ECLIPSE study were eliminated from the summary of phenotypes analyzed in both ECLIPSE and ICGN cohorts.

*

In the ICGN, FEV1/VC was analyzed.

Phenotypes not available or analyzed in ICGN study. All 1,719 ECLIPSE subjects were included in the mean and SD estimates.

Expressed in Ω calculated using the method previously described (18).

§

BODE index calculated using the method previously described (17).

Percentage of lung voxels with x-ray attenuation values less than −950 HU assessed by image analysis of high-resolution computed tomography scans.

Square root of the wall area at a luminal perimeter of 10 mm.